Skip to main content
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
74.49
+1.23 (1.68%)
At close: Mar 9, 2026, 4:00 PM EDT
74.49
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Tarsus Pharmaceuticals Revenue

In the year 2025, Tarsus Pharmaceuticals had annual revenue of $451.36M with 146.71% growth. Tarsus Pharmaceuticals had revenue of $151.67M in the quarter ending December 31, 2025, with 128.39% growth.

Revenue (ttm)
$451.36M
Revenue Growth
+146.71%
P/S Ratio
7.01
Revenue / Employee
$1,219,892
Employees
370
Market Cap
3.17B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025451.36M268.41M146.71%
Dec 31, 2024182.95M165.51M948.62%
Dec 31, 202317.45M-8.37M-32.42%
Dec 31, 202225.82M-31.21M-54.73%
Dec 31, 202157.03M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Catalyst Pharmaceuticals 588.99M
Arcutis Biotherapeutics 376.07M
Arcus Biosciences 247.00M
IDEAYA Biosciences 218.71M
Viridian Therapeutics 70.85M
Dianthus Therapeutics 2.04M
Revenue Rankings

TARS News

More News